Persius/hicric huggingface dataset:
Appeal type: unknown
Decision: unknown

 
The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. 
You can find this rule at 42 Code of Federal Regulations (CFR) Section 422.101. 
 
The rules say that a Medicare plan may restrict members to a network of providers as long as medically 
necessary covered care is accessible and available through this network. The rules say that the Plan must 
arrange for specialty care outside of the Plan provider network when network providers are unavailable or 
inadequate to meet a member's medical needs. You can find this rule at 42 CFR Section 422.112(a)(3). 
 
If you want to read these Medicare rules, you can go to this website www.medicareappeal.com. 
 
The Plan contract says that the Plan covers items and services in accordance with Medicare rules. The Plan 
contract says that, with limited exceptions, members of the Plan must use network providers to get medical care 
and services. The only exceptions are emergencies, urgently needed care when the network is not available 
(generally, when the enrollee is out of the area), out-of-area dialysis services, and cases in which the Plan 
authorizes the use of out-of-network providers. You can find this information on pages 41-42 of the Plans 
2022 Evidence of Coverage (EOC).
Appeal type: unknown
Decision: unknown

 
The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. 
You can find this rule at 42 Code of Federal Regulations (CFR) Section 422.101. 
 
The rules state that continued coverage of a PAP device (E0470 or E0601) beyond the first three months of 
therapy requires that, no sooner than the 31st day but no later than the 91st day after initiating therapy, the 
treating practitioner must conduct a clinical re-evaluation and document that the beneficiary is benefiting from 
PAP therapy. 
 
For PAP devices with initial dates of service on or after November 1, 2008, documentation of clinical benefit is 
demonstrated by: 
 
    In-person clinical re-evaluation by the treating practitioner with documentation that symptoms of obstructive 
sleep apnea are improved; and, 
 
    Objective evidence of adherence to use of the PAP device, reviewed by the treating practitioner. 
 
 
Adherence to therapy is defined as use of PAP =4 hours per night on 70% of nights during a consecutive thirty 
(30) day period anytime during the first three (3) months of initial usage. 
 
If the above criteria are not met, continued coverage of a PAP device and related accessories will be denied as 
not reasonable and necessary. 
 
You can find this information in the Local Coverage Determination (LCD) Positive Airway Pressure (PAP) 
Devices for the Treatment of Obstructive Sleep Apnea L33718. 
 
If you want to read these Medicare rules, you can go to this website www.medicareappeal.com.
Appeal type: unknown
Decision: unknown

 
The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. 
You can find this rule at 42 Code of Federal Regulations (CFR) Section 422.101. 
 
The rules say that a repeat epidural steroid injection (ESI) when the first injection directly and significantly 
provided improvement of the condition being treated may be considered medically reasonable and necessary 
when the medical record documents at least 50% of sustained improvement in pain relief and/or improvement 
in function measured from baseline using same scale for at least three months. If a patient fails to respond well 
to the initial ESI, a repeat ESI after 14 days can be performed using a different approach, level and/or 
medication, if appropriate, with the rationale and medical necessity for the second ESI documented in the 
medical record. You can find this information in Local Coverage Determination (LCD): Epidural Steroid 
Injection for Pain Management (L36920). 
 
If you want to read these Medicare rules, you can go to this website www.medicareappeal.com. 
 
The Plan contract says that the Plan covers items and services in accordance with Medicare rules.
Appeal type: unknown
Decision: unknown

 
The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. 
You can find this rule at 42 Code of Federal Regulations (CFR) Section 422.101. 
 
 
 
 
  
  The rules say that Medicare plans must make reasonable and diligent efforts to gather and forward information 
to the Independent Review Entity (IRE). You can find this information in the Centers for Medicare and 
Medicaid Services, Internet Only Manual, Parts C & D Enrollee Grievances, Organization/Coverage 
Determinations, and Appeals Grievance Manual, Section 50.12.1. 
 
The rules say that Plans are allowed to apply Step therapy to new prescriptions for Medicare Part B covered 
drugs. When implementing this, Plans must establish policies and procedures to educate enrollees concerning 
its step therapy practices. You can find this information in the 42 CFR Section 422.136. 
 
The rules also say that if a Plan decides to adopt and apply step therapy to Part B drugs, the Plan must disclose 
that Part B drugs may be subject to step therapy requirements in the Plans Annual Notice of Change (ANOC) 
and Evidence of Coverage (EOC) documents. In the EOC, this information must be included in the Medical 
Benefits Chart under Medicare Part B prescription drugs". You can find this information in the Centers for 
Medicare/Medicaid Service (CMS) memorandum entitled Prior Authorization and Step Therapy for Part B 
Drugs in Medicare Advantage. 
 
If you want to read these Medicare rules, you can go to this website www.medicareappeal.com.
Appeal type: unknown
Decision: unknown

 
The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. 
You can find this rule at 42 Code of Federal Regulations (CFR) Section 422.101. 
 
The rules say a health plan must disclose to its enrollees in clear, accurate terms all cost sharing information 
(such as copayments, deductibles and coinsurance). You can find this rule at 42 CFR Section 422.111(a) and 
(b). 
 
The rules say that a copayment is a fixed amount charged to an enrollee on a per-service basis. The rules say 
that coinsurance is a fixed percentage of the total amount paid for a health care service that can be charged to 
an enrollee on a per-service basis. You can find this rule at 42 CFR Section 422.2. 
 
If you want to read these Medicare rules, you can go to this website www.medicareappeal.com. 
 
The Plan contract says that the Plan covers items and services in accordance with Medicare rules. The Plan 
contract says that enrollees must pay a $40 copayment for telehealth mental health and psychiatric visit. You 
can find this information on page 86 of the Plan's 2021 Evidence of Coverage (EOC).
Appeal type: unknown
Decision: unknown

 
The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. 
You can find this rule at 42 Code of Federal Regulations (CFR) Section 422.101. 
 
The rules state that under the Outpatient Prospective Payment System (OPPS), packaged services are items and 
services that are considered to be an integral part of another service that is paid under the OPPS. No separate 
payment is made for packaged services, because the cost of these items and services is included in the payment 
for the service of which they are an integral part. For example, routine supplies, anesthesia, recovery room use, 
and most drugs are considered to be an integral part of a surgical procedure so payment for these items is 
packaged into the payment for the surgical procedure.  
 
Unconditionally packaged services are services for which separate payment is never made because the 
payment for the service is always packaged into the payment for other services. Unconditionally packaged 
services are identified in the OPPS Addendum B with status indictor of N.  
 
Q4 services are assigned to laboratory codes that appear on the Clinical Laboratory Fee Schedule 
(CLFS). Status indicator Q4 designates packaged APC payment if billed on the same claim as a code assigned 
status indicator J1, J2, S, T, V, Q1, Q2, or Q3. When a Q4 service is not 
billed on the same claim as another separately payable service then their status indicator automatically changes 
to A and separate payment is made.  
 
You can find this information in the Centers for Medicare and Medicaid Services, Internet-Only Manual, 
Publication 100-04, Medicare Claims Processing Manual, Chapter 4, Section 10.4. 
 The rules say that Medicare plans must make reasonable and diligent efforts to gather and forward information 
to the Independent Review Entity (IRE). You can find this information in the Centers for Medicare and 
Medicaid Services, Internet Only Manual, Parts C & D Enrollee Grievances, Organization/Coverage 
Determinations, and Appeals Guidance Manual, Section 50.12.1. 
 
If you want to read these Medicare rules, you can go to this website www.medicareappeal.com. 
 
The Plan contract says that the Plan covers items and services in accordance with Medicare rules.
Appeal type: unknown
Decision: unknown

 
The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. 
You can find this rule at 42 Code of Federal Regulations (CFR) Section 422.101. 
 
The rules say a health plan must disclose to its enrollees in clear, accurate terms all cost sharing information 
(such as copayments, deductibles and coinsurance). You can find this rule at 42 CFR Section 422.111(a) and 
(b). 
 
The rules say that a copayment is a fixed amount charged to an enrollee on a per-service basis. The rules say 
that coinsurance is a fixed percentage of the total amount paid for a health care service that can be charged to 
an enrollee on a per-service basis. You can find this rule at 42 CFR Section 422.2. 
 
If you want to read these Medicare rules, you can go to this website www.medicareappeal.com. 
 
The Plan contract says that the Plan covers items and services in accordance with Medicare rules. The Plan 
contract says that enrollees must pay $370 per day for other outpatient procedures and services, including but 
not limited to diagnostic and therapeutic endoscopy, and outpatient surgery performed in an outpatient hospital 
or ambulatory surgical center. You can find this information on page 106 of the Plan's 2022 Evidence of 
Coverage (EOC).
Appeal type: unknown
Decision: unknown

 
The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. 
You can find this rule at 42 Code of Federal Regulations (CFR) Section 422.101. 
 
The rules state that coverage of endovenous ablation therapy is limited to patients with:  
 
 a maximum vein diameter of 12 mm for CAE, PEM and MOCA; and 
 absence of thrombosis or vein tortuosity, which would impair catheter advancement (except for 
PEM). 
 
You can find this information in Local Coverage Determination (LCD): Varicose Veins of the Lower 
Extremity, Treatment of (L33575). 
 
If you want to read these Medicare rules, you can go to this website www.medicareappeal.com. 
 
The Plan contract says that the Plan covers items and services in accordance with Medicare rules.
Appeal type: unknown
Decision: unknown

 
The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. 
You can find this rule at 42 Code of Federal Regulations (CFR) Section 422.101. 
 
The rules state that that payment may be made for a one-time ultrasound screening for abdominal aortic 
aneurysm (AAA) for beneficiaries who meet the following criteria: 
 
receives a referral for such an ultrasound screening from the beneficiary's attending physician, physician 
assistant, nurse practitioner or clinical nurse specialist; 
    
receives such ultrasound screening from a provider or supplier who is authorized to provide covered ultrasound 
diagnostic services; 
    
has not been previously furnished such an ultrasound screening under the Medicare Program; and 
    
is included in at least one of the following risk categories-- 
 
has a family history of abdominal aortic aneurysm; 
    
is a man age 65 to 75 who has smoked at least 100 cigarettes in his lifetime; or 
    
is a beneficiary who manifests other risk factors in a beneficiary category recommended for screening by the 
United States Preventive Services Task Force regarding AAA, as specified by the Secretary of Health and 
Human Services, through the national coverage determination process. 
 
You can find this information in the Centers for Medicare and Medicaid Services, Internet Only Manual, 
Publication 100-04, Medicare Claims Processing Manual, Chapter 18, 110.2. 
 
If you want to read these Medicare rules, you can go to this website www.medicareappeal.com. 
 
The Plan contract says that the Plan covers items and services in accordance with Medicare rules. The Health 
Plan contract says that a one-time screening ultrasound for people at risk may be covered. The plan only covers 
this screening if you have certain risk factors and if you get a referral for it from your physician, physician 
assistant, nurse practitioner, or clinical nurse specialist. You can find this information on page 26 of the Plans 
2022 EOC.
Appeal type: unknown
Decision: unknown

 
The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. 
You can find this rule at 42 Code of Federal Regulations (CFR) Section 422.101. 
 
 
  
  
  The rules say that Medicare may cover medically accepted off-label uses for Food and Drug Administration 
(FDA) approved drugs used in an anti-cancer chemotherapeutic regimen. Medicare maintains a list of 
compendia which define if a use is medically accepted. The off-label use must be supported in one or more of 
these compendia or in published, peer-reviewed medical literature. An off-label use must be supported in one 
or more of the compendia and the use must not be listed as unsupported, not indicated, not recommended, or 
equivalent terms, in any of the compendia. An off-label use may also be determined by the carrier in the state 
to be reasonable and necessary. You can find these rules and the list of the Medicare-recognized compendia in 
the Centers for Medicare and Medicaid Services, Internet Only Manual, Publication 100-02, Medicare Benefit 
Policy Manual, Chapter 15, Section 50.4.5. 
 
If you want to read these Medicare rules, you can go to this website www.medicareappeal.com. 
 
The Plan contract says that the Plan covers items and services in accordance with Medicare rules.
Appeal type: unknown
Decision: unknown

 
The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. 
You can find this rule at 42 Code of Federal Regulations (CFR) Section 422.101. 
 
If you want to read these Medicare rules, you can go to this website www.medicareappeal.com. 
 
The Plan contract says that the Plan covers items and services in accordance with Medicare rules. The Plan 
contract also says physician/practitioner services, including doctors office visits requires prior authorization. 
You can find this information on page 93 of the Plan's 2022 Evidence of Coverage.
Appeal type: unknown
Decision: unknown

 
The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. 
You can find this rule at 42 Code of Federal Regulations (CFR) Section 422.101. 
 
The rules say that for services performed on or after January 21, 2020, Medicare will now provide limited 
coverage of acupuncture for patients with chronic low back pain (CLBP). For the purposes of this coverage, 
CLBP is defined as lasting 12 or more weeks, non-specific (meaning there is no identifiable systemic cause, 
such as metastatic, inflammatory, infectious disease), and not associated with either surgery or pregnancy. This 
benefit covers up to 12 sessions in a 90-day period, and up to 20 visits per year, if there is demonstrated 
improvement. Treatment must be discontinued if there is no improvement or regression. These treatments may 
be provided by a physician in accordance with state requirements, or by physician assistants, nurse 
practitioners/clinical nurse specialists, and auxiliary personnel if they meet certain licensure requirements. 
Auxiliary personnel furnishing acupuncture must be under the appropriate level of supervision of a physician, 
physician assistant, or nurse practitioner/clinical nurse specialist. You can find this information in the Centers 
for Medicare and Medicaid Services, Internet Only Manual, Publication 100-03, Medicare National Coverage 
Determinations Manual, Section 30.3.3. 
 
If you want to read these Medicare rules, you can go to this website www.medicareappeal.com. 
 
The Plan contract says that the Plan covers items and services in accordance with Medicare rules. The Plan 
contract says that we cover up to 12 acupuncture visits in 90 days for chronic low back pain. The services must 
be provided by physician assistants, nurse practitioners/clinical nurse specialists, and auxiliary personnel under 
the appropriate level of supervision of a physician, PA, or NP/CNS. You can find this information on page 66 
of the 2022 Evidence of Coverage (EOC).
Appeal type: unknown
Decision: unknown

 
The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. 
You can find this rule at 42 Code of Federal Regulations (CFR) Section 422.101. 
 
The LCD used by the plan is invalid, as it does not address sacroplasty. 
 
The rules say that medically necessary services are those that are reasonable and necessary for the diagnosis or 
treatment of an illness or injury. Medically necessary services include services to improve the functioning of a 
malformed body member. You can find this rule in the Social Security Act, Section 1862(a)(1)(A). 
 
The rules say that services that are not medically necessary are not covered. The rules also say that 
experimental and investigational devices are not covered. You can find this rule at 42 CFR Sections 411.15 and 
411.15(o). 
 
If you want to read these Medicare rules, you can go to this website www.medicareappeal.com. 
 
The Plan contract says that the Plan covers items and services in accordance with Medicare rules.
Appeal type: unknown
Decision: unknown

 
The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. 
You can find this rule at 42 Code of Federal Regulations (CFR) Section 422.101. 
 
The rules state that when submitting Medicare claims, units of service (UOS) should be reported in multiples of 
the dosage included in the long HCPCS code descriptor. If the provider must discard the remainder of a single-
use vial or other package after administering the prescribed dosage of any given drug, Medicare may cover the 
amount of the drug discarded along with the amount administered. This coverage requires that the vial is 
single-use, and the units billed must correspond with the smallest dose (vial) available for purchase from the 
manufacturer(s) that could provide the appropriate dose for the patient, while minimizing any wastage. 
 
You can find this information in the Local Coverage Article (LCA): Billing and Coding: JW Modifier Billing 
Guidelines (A53024). 
 
If you want to read these Medicare rules, you can go to this website www.medicareappeal.com. 
 
The Plan contract says that the Plan covers items and services in accordance with Medicare rules.
Appeal type: unknown
Decision: unknown

 
The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. 
You can find this rule at 42 Code of Federal Regulations (CFR) Section 422.101. 
 
The rules say that local Medicare coverage of biomarkers must be predicated upon three fundamental 
principles: 
 
1. First, there must be an underlying performance of acceptable, high-quality analytical validity for all such 
laboratory testing. As a result, the laboratory shall have available upon request: 
 
-Analytical and clinical validation reports for Clinical Laboratory Improvement Amendments (CLIA), 
including the test description, intended use, and indications for testing. 
-If applicable, all formal, written minutes and correspondences (including any Q & A and supporting 
documentation) with the New York State Department of Health (NYSDOH) or the United States (U.S.) Food 
and Drug Administration (FDA). 
-Most recent inspection results (including recommendations) or scheduled inspection(s) from CLIA, College of 
American Pathologists (CAP), or NYSDOH, as applicable. 
 
2. Second, there must be an appreciation of evidence-in-transition where new biomarkers should be brought on-
line in harmonization with their proven clinical validity/utility (CVU). Although analytical validity is an 
equally important metric, it remains more outside of a payer's purview to conduct such detailed evaluations. 
Therefore, in the absence of a standard CVU referee process (e.g., although FDA labeling of biomarkers can be 
a helpful adjunct, it may not always be relevant), the key imperative is for medical necessity to be reflected by 
the clear articulation of a particular biomarker niche. 
 
3. Third, there must be a recognized decision impact of such biomarkers by the clinical community. In other 
words, there must be acceptance/uptake of specific testing into patient management. It should be taken into 
account that to reach the medical necessity threshold, such acceptance should be based on the strongest 
evidence available, ideally from along the spectrum of high-quality masked, randomized controlled clinical 
trials, and much less preferably from lower levels of evidence, which are predicated upon expert opinion only 
without primary study data. 
 
You can find this rule in the Local Coverage Determination (LCD) - Biomarkers Overview (L35062) - 
Effective October 1, 2015. 
 
If you want to read these Medicare rules, you can go to this website www.medicareappeal.com. 
 The Plan contract says that the Plan covers items and services in accordance with Medicare rules.
Appeal type: unknown
Decision: unknown

 
The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. 
You can find this rule at 42 Code of Federal Regulations (CFR) Section 422.101. 
 
The rules say that plans must pay for ambulance services when an emergency exists or when other means of 
transport would endanger the patients health. An emergency is defined as when a prudent layperson would 
believe that without immediate medical attention there would be serious jeopardy to his or her health. You can 
find these rules in the Centers for Medicare and Medicaid Services, Internet Only Manual, Publication 100-16, 
Medicare Managed Care Manual, Chapter 4, Sections 20.1 and 20.2. 
 
If you want to read these Medicare rules, you can go to this website www.medicareappeal.com. 
 
The Plan contract says that the Plan covers items and services in accordance with Medicare rules. The Plan 
contract also says that the Plan covers ambulance services. Covered ambulance services include fixed wing, 
rotary wing, and ground ambulance services, to the nearest appropriate facility that can provide care only if 
they are furnished to a member whose medical condition is such that other means of transportation could 
endanger the persons health or if authorized by the Plan. A $175 copay for Medicare- covered ground 
ambulance benefits. Waived if admitted. You can find this information on pages 65 and 66 of the Plan's 2022 
Evidence of Coverage.